ValueQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSelling/general/admin expenses62.34 M57.37 M65.72 M69.46 M91.72 M284.27 MResearch & development93.63 M99.84 M112.55 M99.23 M104.4 M416.03 MOperating income-139.04 M-155.63 M-111.51 M-166.75 M-178.37 M-612.26 MNon-Operating Income, Total15.01 M13.7 M13 M10.25 M11.47 M48.42 MInterest expense, net of interest capitalized8.94 M8.87 M11.08 M11.35 M14.27 M45.58 MNon-Operating Income, excl. Interest Expenses6.08 M4.83 M1.92 M-1.1 M-2.8 M2.84 MUnusual income/expense——————Pretax income-124.03 M-141.93 M-98.5 M-156.51 M-166.9 M-563.84 MEquity in earnings——————Taxes————-21.3 M—Non-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations-150.02 M-161.38 M-134.37 M-306.18 M-183.03 M-784.96 MDiscontinued operations——————Net income-150.02 M-161.38 M-134.37 M-306.18 M-183.03 M-784.96 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders-150.02 M-161.38 M-134.37 M-306.18 M-183.03 M-784.96 MBasic earnings per share (Basic EPS)-1.26-1.36-1.12-2.55-1.51-6.54Diluted earnings per share (Diluted EPS)-1.26-1.36-1.12-2.55-1.51-6.54Average basic shares outstanding111.98 K118.5 K119.46 K119.98 K120.1 K478.04 KDiluted shares outstanding111.98 K118.5 K119.46 K119.98 K120.1 K478.04 KEBITDA-136.66 M-153.33 M-109.22 M-164.08 M-175.5 M-602.13 MEBIT-139.04 M-155.63 M-111.51 M-166.75 M-178.37 M-612.26 MCost of revenue——————Other cost of goods sold——————Depreciation & amortization (cash flow)2.38 M2.3 M2.29 M2.68 M2.86 M10.13 M
Cytokinetics Incorporated
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.